Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Wolfe Research Upgrades Matson to Peer Perform

Wolfe Research Upgrades Matson to Peer Perform

Wolfe Research analyst Scott Group upgrades Matson (NYSE:MATX) from Underperform to Peer Perform.

November 17, 2022

1 minute read

Wolfe Research analyst Scott Group upgrades Matson (NYSE:MATX) from Underperform to Peer Perform.

Roth Capital Downgrades Catalyst Pharmaceuticals to Neutral, Raises Price Target to $15.5

August 24, 9:27 AM

Roth Capital analyst Scott Henry downgrades Catalyst Pharmaceuticals (NASDAQ:CPRX) from Buy to Neutral and raises the price target from $10 to $15.5.

October 3, 5:00 PM

Kellanova (NYSE:K) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

January 10, 12:00 PM

4 analysts have expressed a variety of opinions on Kemper (NYSE:KMPR) over the past quarter, offering a diverse…

May 10, 2:12 PM

Needham analyst Matt McGinley reiterated a Buy rating on the shares of BellRing Brands, Inc. (NYSE:BRBR), raising the target price to $44…